Literature DB >> 15654632

Operative indications and neuroendoscopic management of symptomatic cysts of the septum pellucidum.

Tamotsu Miki1, Jun Wada, Nobuyuki Nakajima, Tadayoshi Inaji, Jiro Akimoto, Jo Haraoka.   

Abstract

OBJECTIVE: Since there is no current consensus on the diagnostic standards or surgical indications for symptomatic cysts of the septum pellucidum (CSP), we presented our experience treating such cases with neuroendoscopic surgery in order to possibly make a contribution to the attainment of such a consensus.
METHODS: In the last 5 years, we effectively treated 5 patients (4 males and 1 female) with CSP by neuroendoscopic surgery. The 3 congenital cases were young: 9, 14, and 29 years old. The 2 secondary cases were adults aged 51 and 65 years old. We were able to fenestrate, and biopsy for pathological analysis, the cyst walls of symptomatic CSP using a minimally invasive neuroendoscopic technique, with postoperative improvement in compression of adjacent structures, as well as clinical signs.
CONCLUSIONS: It is necessary to consider the overall picture including clinical signs, progress of the condition, intracranial pressure, and cerebral circulation, in deciding whether surgery is indicated. Neuroendoscopic surgery is an effective, optimal, and convenient therapeutic modality for symptomatic CSP.

Entities:  

Mesh:

Year:  2005        PMID: 15654632     DOI: 10.1007/s00381-004-1063-7

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  24 in total

1.  Caves and cysts of the septum pellucidum.

Authors:  R A HUGHES; J W KERNOHAN; W M CRAIG
Journal:  AMA Arch Neurol Psychiatry       Date:  1955-09

2.  Morphology and immunohistochemistry of a symptomatic septum pellucidum cavum Vergae cyst in man.

Authors:  E Ronsin; D Grosskopf; J Perre
Journal:  Acta Neurochir (Wien)       Date:  1997       Impact factor: 2.216

3.  Cava septi pellucidi et vergae: their normal and pathogical states.

Authors:  C M Shaw; E C Alvord
Journal:  Brain       Date:  1969-03       Impact factor: 13.501

4.  Expanded cavum septi pellucidi and cavum vergae associated with behavioral symptoms relieved by a stereotactic procedure: case report.

Authors:  T Miyamori; K Miyamori; T Hasegawa; K Tokuda; Y Yamamoto
Journal:  Surg Neurol       Date:  1995-11

5.  Laser-assisted flexible endoscopic fenestration of giant cyst of the septum pellucidum.

Authors:  A Jackowski; M Kulshresta; S Sgouros
Journal:  Br J Neurosurg       Date:  1995       Impact factor: 1.596

6.  Stereotactic management of congenital midline cysts.

Authors:  P Behrens; C B Ostertag
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

7.  Clinical correlates of septum pellucidum cavities: an unusual association with psychosis.

Authors:  S W Lewis; G C Mezey
Journal:  Psychol Med       Date:  1985-02       Impact factor: 7.723

8.  Wide cavum septum pellucidum: a marker of disturbed brain development.

Authors:  J B Bodensteiner; G B Schaefer
Journal:  Pediatr Neurol       Date:  1990 Nov-Dec       Impact factor: 3.372

9.  Giant cyst of the septum pellucidum: case report.

Authors:  R Garza-Mercado
Journal:  J Neurosurg       Date:  1981-10       Impact factor: 5.115

10.  Cavum vergae cyst as a cause of hydrocephalus, "almost forgotten"? Successful stereotactic treatment.

Authors:  E Donauer; J R Moringlane; C B Ostertag
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

View more
  2 in total

1.  Cavum septum pellucidum cyst in children: a case-based update.

Authors:  Alin Borha; Keven F Ponte; Evelyne Emery
Journal:  Childs Nerv Syst       Date:  2012-04-29       Impact factor: 1.475

2.  Expanding Cyst of the Septum Pellucidum - Endoscopic Observations on the Mechanism of Development and Results of Treatment.

Authors:  Leszek Sagan; Bartosz Limanówka; Leszek Herbowski; Wojciech Poncyljusz; Maria Giżewska
Journal:  Neurol Med Chir (Tokyo)       Date:  2020-03-05       Impact factor: 1.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.